Scopolamine Transdermal System Patch, Extended Release
Product Images NDC 71335-2718

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Scopolamine Transdermal System (NDC 71335-2718). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Extended Label (713352718 E Label)

Extended Label (713352718 E Label)
Drug facts text panel for scopolamine transdermal system describing dosage and administration instructions. It details the application procedure including washing hands, using one patch at a time, placement behind the ear, and precautions such as avoiding cutting the patch and removing it before MRI procedures. It also mentions inactive ingredients and warnings about possible side effects like drowsiness and blurred vision.*
FDA Label Image

Cross-section (Cross Section)

Cross-section (Cross Section)
A diagram illustrating the layered structure of a scopolamine transdermal system patch. The labeled layers include the Release Liner at the bottom, Contact Layer, Rate Controlling Membrane, Drug Layer, and Backing Membrane at the top, demonstrating the patch's design for extended release delivery.*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
An instructional diagram showing hands holding a small, tan-colored, imprinted transdermal system patch. The diagram labels the metallic adhesive surface and the clear, disposable release liner being peeled off the patch.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
An instructional diagram of the Scopolamine Transdermal System patch showing its clear disposable release liner, metallic adhesive surface, and tan backing membrane with imprint 'SCOP 1 mg/3 days.'*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
An instructional illustration showing how to open the package by cutting along a dashed line with scissors. The image outlines a rectangular patch inside the package and indicates the cut line for opening.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
An instructional illustration showing hands peeling apart a protective backing from a transdermal patch, revealing the adhesive side for application. This image is typical for demonstrating the preparation of the Scopolamine Transdermal System patch before use.*
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
An illustration shows the side view of a person's head with a tan-colored transdermal system applied behind the ear. The image labels the patch as a 'tan-colored transdermal system,' indicating proper placement for the Scopolamine Transdermal System.*
FDA Label Image

Label (Lbl713352718)

Label (Lbl713352718)
Label for Scopolamine Transdermal System 1 mg/3 days extended-release patch by Bryant Ranch Prepack. The label indicates a package of 10 systems, includes storage instructions, cautions about drowsiness and blurred vision, and directs users to scan a QR code for dosage and prescribing details. It also states that the system is foil-sealed for protection and should not be used if the seal is broken.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of scopolamine, the active ingredient in Scopolamine Transdermal System 1 mg/1 patch by Bryant Ranch Prepack. The diagram shows the molecular arrangement including rings and functional groups characteristic of scopolamine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.